Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
<< anterior 21 a 40 de 569 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Anónimo. Indapamide + amlodipine. Prescrire 2015;35:7. [Ref.ID 98895]
22.Tiene citas relacionadas Cita con resumen
Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, Paraq V, Harwood M, Doughty RN, Arroll B, Milne RJ, Bramley D, Bryant L, Jackson R, Rodgers A. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care. BMJ 2014;348:g3318. [Ref.ID 98026]
23. Cita con resumen
Makam AN, Boscardin WJ, MIao Y, Steinman MA. Risk of thiazide-induced metabolic adverse events in older adults. J Am Geriatr Soc 2014;62:1039-45. [Ref.ID 97695]
25. Cita con resumen
Trullàs JC, Morales-Rull JL, Formiga F. Tratamiento diurético en la insuficiencia cardíaca. Med Clin (Barc) 2014;142:163-70. [Ref.ID 97267]
26. Cita con resumen
Muneer A, Kalsi J, Nazareth I, Arya M. Erectile dysfunction. BMJ 2014;348:g129. [Ref.ID 97218]
28.Tiene citas relacionadas Cita con resumen
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith Jr SC, Svetkey LP, Taler SJ, Townsend RR, Wright Jr JT, Narva AS, Ortiz E. 2014 evidence based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20. [Ref.ID 97094]
29.Tiene citas relacionadas
Bauchner H, Fontanarosa PB, Golub RM. Updated guidelines for management of high blood pressure: recommendation, review, and responsibility. JAMA 2014;311:477-8. [Ref.ID 97092]
30.Tiene citas relacionadas
Peterson ED, Gaziano JM, Greenland P. Recommendations for treating hypertension: what are the right goals and purposes?. JAMA 2014;311:474-6. [Ref.ID 97091]
32. Cita con resumen
Andrews PA. Gout. Effect of commonly prescribed drugs on incidence of gout. BMJ 2013;347:22. [Ref.ID 96433]
33.Tiene citas relacionadas Cita con resumen
Thom S, Poulter N, Field J, Patel A, Prabhakaran D, Stanton A, Grobbee DE, Bots ML, Reddy KS, Cidambi R, Bompoint S, Billot L, Rodgers A, UMPIRE Collaborative Group. Effects of a fixed -dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA 2013;310:918-29. [Ref.ID 96053]
34.Tiene citas relacionadas
Gaziano JM. Progress with the polypill?. JAMA 2013;310:910-1. [Ref.ID 96052]
35.Tiene citas relacionadas
Dhalla IA, Mamdani MM, Juurlink DN. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:923-4. [Ref.ID 95693]
36.Tiene citas relacionadas
Einhom PT, Cushman WC, Whelton PK, for the ALLHAT Collaborative Research Group. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:922-3. [Ref.ID 95692]
37.Tiene citas relacionadas
Donzelli A. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:921-2. [Ref.ID 95691]
38.Tiene citas relacionadas
Badgett RG. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:921. [Ref.ID 95690]
39.Tiene citas relacionadas
DiNicolantonio JJ, O'Keefe JH, Lavie CJ. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:920-1. [Ref.ID 95689]
40.Tiene citas relacionadas
Roush GC, Holford TR, Guddati AK. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:920. [Ref.ID 95688]
Seleccionar todas
 
<< anterior 21 a 40 de 569 siguiente >>